Open AccessMolecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia
Author(s) -
Naseema Gangat,
Isla McKerrow Johnson,
Kristen McCullough,
Faiqa Farrukh,
Aref AlKali,
Hassan B. Alkhateeb,
Kebede Begna,
Abhishek Mangaonkar,
Mark R. Litzow,
William J. Hogan,
Mithun Vinod Shah,
Mrinal M. Patnaik,
Animesh Pardanani,
Ayalew Tefferi
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2022.281214
Subject(s) - venetoclax , hypomethylating agent , myeloid leukemia , medicine , myeloid , oncology , azacitidine , leukemia , cancer research , immunology , biology , genetics , gene , dna methylation , chronic lymphocytic leukemia , gene expression